Efficacy and safety of dupilumab in children aged ≥6 months to <6 years with moderate-to-severe atopic dermatitis

被引：0
|
作者：
Paller, Amy S.
Siegfried, Elaine C.
Simpson, Eric L.
Wollenberg, Andreas
Gonzalez, Mercedes E.
Sidbury, Robert
Lockshin, Benjamin
Xiao, Jing
O'Malley, John T.
Bansal, Ashish
机构：
来源：
ALLERGY AND ASTHMA PROCEEDINGS | 2022年 / 43卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：561 / 561
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of dupilumab treatment with concomitant topical corticosteroids in children aged 6 months to 5 years with severe atopic dermatitis
    Paller, Amy S.
    Pinter, Andreas
    Lee, Lara Wine
    Aschoff, Roland
    Zdybski, Jacek
    Schnopp, Christina
    Praestgaard, Amy
    Bansal, Ashish
    Shumel, Brad
    Prescilla, Randy
    Bastian, Mike
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [22] Efficacy and safety of dupilumab treatment with concomitant topical corticosteroids in children aged 6 months to 5 years with severe atopic dermatitis
    Paller, A. S.
    Pinter, A.
    Lee, L. Wine
    Aschoff, R.
    Zdybski, J.
    Schnopp, C.
    Praestgaard, A.
    Bansal, A.
    Shumel, B.
    Prescilla, R.
    Bastian, M.
    ALLERGY, 2023, 78 : 194 - 195
  • [23] Dupilumab Efficacy in Children With Atopic Dermatitis Aged 6 Months to 5 Years With and Without Atopic Comorbidities
    Boguniewicz, Mark
    Sher, Lawrence
    Paller, Amy
    Chen, Zhen
    Shah, Parul
    Rodriguez-Marco, Ainara
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB148 - AB148
  • [24] Dupilumab provides improvement in sleep in children aged ≥ 6 years with severe atopic dermatitis (AD) and adolescents with moderate-to-severe AD
    Paller, A.
    Wollenberg, A.
    Simpson, E.
    Beck, L.
    Hong, C-H
    Marcoux, D.
    Chen, Z.
    Levit, N.
    Bansal, A.
    Rossi, A.
    Chao, J.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 : 57 - 58
  • [25] Infections in Children Aged 6 Months to 5 Years Treated with Dupilumab in a Placebo-Controlled Clinical Trial of Moderate-to-Severe Atopic Dermatitis
    Paller, Amy S.
    Siegfried, Elaine C.
    Cork, Michael J.
    Arkwright, Peter D.
    Eichenfield, Lawrence F.
    Ramien, Michele
    Khokhar, Faisal A.
    Chen, Zhen
    Zhang, Annie
    Cyr, Sonya L.
    PEDIATRIC DRUGS, 2024, 26 (02) : 163 - 173
  • [26] Infections in Children Aged 6 Months to 5 Years Treated with Dupilumab in a Placebo-Controlled Clinical Trial of Moderate-to-Severe Atopic Dermatitis
    Amy S. Paller
    Elaine C. Siegfried
    Michael J. Cork
    Peter D. Arkwright
    Lawrence F. Eichenfield
    Michele Ramien
    Faisal A. Khokhar
    Zhen Chen
    Annie Zhang
    Sonya L. Cyr
    Pediatric Drugs, 2024, 26 : 163 - 173
  • [27] Dupilumab treatment reduces skin pain in infants and young children aged 6 months-5 years with moderate-to-severe atopic dermatitis
    Paller, Amy S.
    Silverberg, Jonathan I.
    Siegfried, Elaine C.
    Gonzalez, Mercedes E.
    Schneider, Lynda C.
    Sidbury, Robert
    Zhang, Haixin
    Prescilla, Randy
    Wang, Zhixiao
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E101 - E101
  • [28] Laboratory Safety from a Randomized 16-Week Phase III Study of Dupilumab in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis
    Paller, Amy S.
    Siegfried, Elaine C.
    Cork, Michael J.
    Wollenberg, Andreas
    Arkwright, Peter D.
    Gonzalez, Mercedes E.
    Lockshin, Benjamin
    Chen, Zhen
    Bansal, Ashish
    Levit, Noah A.
    Prescilla, Randy
    PEDIATRIC DRUGS, 2023, 25 (01) : 67 - 77
  • [29] Laboratory Safety from a Randomized 16-Week Phase III Study of Dupilumab in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis
    Amy S. Paller
    Elaine C. Siegfried
    Michael J. Cork
    Andreas Wollenberg
    Peter D. Arkwright
    Mercedes E. Gonzalez
    Benjamin Lockshin
    Zhen Chen
    Ashish Bansal
    Noah A. Levit
    Randy Prescilla
    Pediatric Drugs, 2023, 25 : 67 - 77
  • [30] Efficacy and safety of dupilumab in children aged 6 months to 5 years with atopic dermatitis with and without type 2 comorbidities
    Boguniewicz, M.
    Sher, L.
    Paller, A. S.
    Chen, Z.
    Shah, P.
    Marco, A. Rodriguez
    ALLERGY, 2023, 78
12345